Study: No Evidence the HPV Vaccine Prevents Cervical Cancer – 54% Increase in Cervical Cancer in British 25 to 29-Year-Olds

Human papillomavirus (HPV) vaccines hit the global marketplace in the mid-2000s. From the start, public health agencies enthusiastically promoted HPV vaccination as the “best way to protect [young people] against certain types of cancer later in life.” However, a blistering new study by British researchers—and new data showing that cervical cancer rates are surging in British 25- to 29-year-olds—raise numerous questions about officials’ inflated claims. The study’s results indicate, instead, that the jury is still out on whether HPV vaccination is effective. The question is far from academic because, prior to Britain’s introduction of HPV vaccination in 2008, cervical cancer rates had been trending sharply downward. In fact, between the late 1980s and mid-2000s, cervical cancer rates halved. Now, Britain’s leading cancer research charity (Cancer Research UK) reports a steep 54% rise in cervical cancer in one of the very age groups that first received the vaccine.

New Research: High HPV Cancer Rates Linked to High Gardasil Vaccination Rates – “Exactly the Opposite of what we Expected”

Last year (2018) we reported on the research of French oncologist Dr. Gérard Delépine, who published an analysis of the HPV vaccine Gardasil showing how increased rates of Gardasil vaccinations are actually correlated with a higher rate of cervical cancer. Now, researchers at the University of South Alabama are observing the same link of increased Gardasil vaccination rates with an increased rate of HPV related cervical cancers in Alabama. The researchers and medical doctors commented that this was a "surprising discovery" and that it was "exactly the opposite of what we expected." It is highly unlikely this will be reported in any of the corporate-sponsored "mainstream" media sources.